BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16690975)

  • 1. Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.
    McKone EF; Shao J; Frangolias DD; Keener CL; Shephard CA; Farin FM; Tonelli MR; Pare PD; Sandford AJ; Aitken ML; Kavanagh TJ
    Am J Respir Crit Care Med; 2006 Aug; 174(4):415-9. PubMed ID: 16690975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.
    Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
    BMC Med Genet; 2014 Mar; 15():27. PubMed ID: 24593045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic interaction of GSH metabolic pathway genes in cystic fibrosis.
    de Lima Marson FA; Bertuzzo CS; Secolin R; Ribeiro AF; Ribeiro JD
    BMC Med Genet; 2013 Jun; 14():60. PubMed ID: 23758905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.
    Chaima S; Sondess HF; Khedija B; Ahmed M; Taieb M
    Ann Biol Clin (Paris); 2020 Jun; 78(3):314-318. PubMed ID: 32540817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL1B polymorphisms modulate cystic fibrosis lung disease.
    Levy H; Murphy A; Zou F; Gerard C; Klanderman B; Schuemann B; Lazarus R; García KC; Celedón JC; Drumm M; Dahmer M; Quasney M; Schneck K; Reske M; Knowles MR; Pier GB; Lange C; Weiss ST
    Pediatr Pulmonol; 2009 Jun; 44(6):580-93. PubMed ID: 19431193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.
    Bremer LA; Blackman SM; Vanscoy LL; McDougal KE; Bowers A; Naughton KM; Cutler DJ; Cutting GR
    Hum Mol Genet; 2008 Jul; 17(14):2228-37. PubMed ID: 18424453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
    Sawicki GS; Van Brunt K; Booth J; Bailey E; Millar SJ; Konstan MW; Flume PA
    J Cyst Fibros; 2022 Jan; 21(1):96-103. PubMed ID: 34289939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients.
    Czerska K; Sobczynska-Tomaszewska A; Sands D; Nowakowska A; Bak D; Wertheim K; Poznanski J; Zielenski J; Norek A; Bal J
    J Appl Genet; 2010; 51(3):323-30. PubMed ID: 20720307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.
    Ferril GR; Nick JA; Getz AE; Barham HP; Saavedra MT; Taylor-Cousar JL; Nichols DP; Curran-Everett D; Kingdom TT; Ramakrishnan VR
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):915-20. PubMed ID: 25224556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.
    Green DM; McDougal KE; Blackman SM; Sosnay PR; Henderson LB; Naughton KM; Collaco JM; Cutting GR
    Respir Res; 2010 Oct; 11(1):140. PubMed ID: 20932301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
    Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.
    Mutesa L; Azad AK; Verhaeghe C; Segers K; Vanbellinghen JF; Ngendahayo L; Rusingiza EK; Mutwa PR; Rulisa S; Koulischer L; Cassiman JJ; Cuppens H; Bours V
    Chest; 2009 May; 135(5):1233-1242. PubMed ID: 19017867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
    Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
    Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.
    Collaco JM; Vanscoy L; Bremer L; McDougal K; Blackman SM; Bowers A; Naughton K; Jennings J; Ellen J; Cutting GR
    JAMA; 2008 Jan; 299(4):417-24. PubMed ID: 18230779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.
    Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
    BMC Pulm Med; 2012 Sep; 12():50. PubMed ID: 22950544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
    Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
    Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability.
    Furlan LL; Marson FA; Ribeiro JD; Bertuzzo CS; Salomão Junior JB; Souza DR
    Hum Genet; 2016 Aug; 135(8):881-94. PubMed ID: 27209008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.